Update on asthma prevalence in severe COVID-19 patients
- PMID: 32639631
- PMCID: PMC7361842
- DOI: 10.1111/all.14482
Update on asthma prevalence in severe COVID-19 patients
Conflict of interest statement
None declared.
Comment in
-
Asthma phenotypes, comorbidities, and disease activity in COVID-19: The need of risk stratification.Allergy. 2021 Mar;76(3):955-956. doi: 10.1111/all.14537. Epub 2020 Aug 24. Allergy. 2021. PMID: 32830862 Free PMC article. No abstract available.
Comment on
-
Is asthma protective against COVID-19?Allergy. 2021 Mar;76(3):866-868. doi: 10.1111/all.14426. Epub 2020 Jun 17. Allergy. 2021. PMID: 32479648 Free PMC article. No abstract available.
References
-
- Khawaja AP, Warwick AN, Hysi PG, et al. Associations with COVID‐19 hospitalisation amongst 406,793 adults: the UK Biobank prospective cohort study. medRxiv. 2020. 10.1101/2020.05.06.20092957 - DOI
-
- Williamson E, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, The OpenSAFELY Collaborative . OpenSAFELY: factors associated with COVID‐19‐related hospital death in the linked electronic health records of 17 million adult NHS patients. medRxiv. 2020. 10.1101/2020.05.06.20092999 - DOI